These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study. Cha W, Jang JY, Wang SG, Kang JH, Jo MG. J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509 [Abstract] [Full Text] [Related]
6. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ. Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424 [Abstract] [Full Text] [Related]
13. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L. J Headache Pain; 2013 Aug 21; 14(1):72. PubMed ID: 23964790 [Abstract] [Full Text] [Related]
19. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses. Hu X, Xia Y, Li J, Wang X, Liu H, Hu J, Bi J, Wu J, Wang T, Lin Z, Xiong N. Clin J Pain; 2024 Jun 01; 40(6):383-392. PubMed ID: 38385501 [Abstract] [Full Text] [Related]